Screener
Ardent Health Partners ARDT Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Ardent Health Partners in its filing.
Tagged under the XBRL concept us-gaap:StockOptionPlanExpense.
The source filing: Ardent Health Partners’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-055215
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Other non-operating (gains) losses | (1,886) | 777 |
| Amortization of deferred financing costs and debt discounts | 1,622 | 2,474 |
| Deferred income taxes | 3,068 | (2,733) |
| Equity-based compensation | 16,881 | 20,509 |
| Income from non-consolidated affiliates | (8,079) | (2,956) |
| Changes in operating assets and liabilities, net of effect of acquisitions and divestitures: | ||
| Accounts receivable | (9,838) | (14,251) |
| Inventories | 2,571 | (3,118) |
Item 6. [Exhibits](#i318ceb938e8c4054acb07fc4f210c650_220) [39](#i318ceb938e8c4054acb07fc4f210c650_220)
FAQ
- What is Ardent Health Partners's stock-based comp?
- Ardent Health Partners (ARDT) reported stock-based comp of $7.95M in Q2 2026.
- How has Ardent Health Partners's stock-based comp changed year-over-year?
- Ardent Health Partners's stock-based comp decreased by 29.3% year-over-year, from $11.25M to $7.95M.
- What is the long-term trend for Ardent Health Partners's stock-based comp?
- Over 2 years (2022 to 2025), Ardent Health Partners's stock-based comp has grown at a 701.9% compound annual growth rate (CAGR), from $611K to $39.29M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Ardent Health Partners's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude